Results 81 to 90 of about 22,562,908 (328)

Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients

open access: yesMolecular Oncology, EarlyView.
Small cell lung cancer (SCLC) is an aggressive form of lung cancer that spreads rapidly to secondary sites such as the brain and liver. Cancer cells circulating in the blood, “circulating tumor cells” (CTCs), have demonstrated prognostic value in SCLC, and evaluating biomarkers on CTCs could guide treatment decisions such as for PARP inhibitors ...
Prajwol Shrestha   +6 more
wiley   +1 more source

Privacy-Aware Data Publishing and Integration for Collaborative Service Recommendation

open access: yesIEEE Access, 2018
Item-based collaborative filtering (i.e., ICF) technique has been widely recruited to make service recommendations in the big data environment. However, the ICF technique only performs well when the data for service recommendation decision-making are ...
Chao Yan   +4 more
semanticscholar   +1 more source

Privacy Preserving Large-Scale Rating Data Publishing

open access: yesEAI Endorsed Transactions on Scalable Information Systems, 2013
Large scale rating data usually contains both ratings of sensitive and non-sensitive issues, and the ratings of sensitive issues belong to personal privacy.
Xiaoxun Sun, Lili Sun
doaj   +1 more source

A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer

open access: yesMolecular Oncology, EarlyView.
Lung cancer cells were spiked into donor blood to evaluate the recovery rates of the following circulating tumor cell (CTC) enrichment technologies: CellMag™, EasySep™, RosetteSep™, Parsortix® PR1, and Parsortix® Prototype systems. Each method's advantages and disadvantages are described.
Volga M Saini   +11 more
wiley   +1 more source

A privacy‐preserving method for publishing data with multiple sensitive attributes

open access: yesCAAI Transactions on Intelligence Technology
The overgeneralisation may happen because most studies on data publishing for multiple sensitive attributes (SAs) have not considered the personalised privacy requirement.
Tong Yi   +3 more
doaj   +1 more source

Heuristics for publishing dynamic content as structured data with schema.org [PDF]

open access: yesarXiv, 2018
Publishing fast changing dynamic data as open data on the web in a scalable manner is not trivial. So far the only approaches describe publishing as much data as possible, which then leads to problems, like server capacity overload, network latency or unwanted knowledge disclosure. With this paper we show ways how to publish dynamic data in a scalable,
arxiv  

Cell‐free and extracellular vesicle microRNAs with clinical utility for solid tumors

open access: yesMolecular Oncology, EarlyView.
Cell‐free microRNAs (cfmiRs) are small‐RNA circulating molecules detectable in almost all body biofluids. Innovative technologies have improved the application of cfmiRs to oncology, with a focus on clinical needs for different solid tumors, but with emphasis on diagnosis, prognosis, cancer recurrence, as well as treatment monitoring.
Yoshinori Hayashi   +6 more
wiley   +1 more source

Privacy Preserving Data Publishing with Multiple Sensitive Attributes based on Overlapped Slicing

open access: yesInf., 2019
Investigation into privacy preserving data publishing with multiple sensitive attributes is performed to reduce probability of adversaries to guess the sensitive values.
Widodo, E. K. Budiardjo, W. Wibowo
semanticscholar   +1 more source

A Contrastive Study of Practical Modes of Data Publishing——Take the Field of Earth Science as an Example

open access: yesZhishi guanli luntan, 2019
[Purpose/significance] Scientific data publishing is the main mode of academic communication for data-intensive scientific discovery, which is of great significance for data reuse and scientific verification.
Han Lu, Ding Yi
doaj   +1 more source

KRAS and GNAS mutations in cell‐free DNA and in circulating epithelial cells in patients with intraductal papillary mucinous neoplasms—an observational pilot study

open access: yesMolecular Oncology, EarlyView.
This study demonstrates that KRAS and GNAS mutations are more prevalent in patients with resected intraductal papillary mucinous neoplasms (IPMN) compared to those under clinical surveillance. GNAS mutations significantly differ between the two patient cohorts, indicating that their absence may serve as a potential biomarker to support conservative ...
Christine Nitschke   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy